Smartwatch ECG app confirms AF at sea; CIRM diverts the ship

On 29 Sep 2023 a merchant ship with no ECG used a smartwatch ECG app under CIRM guidance; it confirmed AF within seconds, the ship diverted, hospital ECG confirmed AF and the seafarer was repatriated.

21ⓘ

AI system

System

Smartwatch ECG application with atrial fibrillation classification (brand and model not stated)

Model

Not assessed

Release

Not assessed

Application developer

Not stated (the report does not name the device's maker)

Role

Not assessed

Configuration

Not assessed

Inputs and outputs

Not assessed

Autonomy

Not assessed

Workflow

A ship without an electrocardiograph but with a smartwatch carrying an ECG app on board. A telemedical maritime assistance service (CIRM) reachable from the ship and willing to act on a smartwatch trace. A captain able to run the app on the patient and to divert the vessel.

Human oversight

Not assessed

Relation to AI

The ECG app's automatic reading confirmed the suspected AF “within seconds”. The CIRM doctor then reviewed the trace himself and identified irregularities consistent with AF. So the classification and the human reading agreed. The diversion, drugs and hospital confirmation were human decisions. The brand is unknown, so the algorithm cannot be identified.

AI contribution

The ECG app's automatic reading confirmed the suspected AF “within seconds”. The CIRM doctor then reviewed the trace himself and identified irregularities consistent with AF. So the classification and the human reading agreed. The diversion, drugs and hospital confirmation were human decisions. The brand is unknown, so the algorithm cannot be identified.

Benefits

Outcome identifiers

Not assessed

Benefit

On 29 Sep 2023 a merchant ship with no ECG used a smartwatch ECG app under CIRM guidance; it confirmed AF within seconds, the ship diverted, hospital ECG confirmed AF and the seafarer was repatriated.

Category

Improved Physical Health

Status

Not assessed

Beneficiary groups

People. Organizations.

Beneficiaries

Not assessed

Reach

Not assessed

Distribution and access

Not assessed

Duration

Not assessed

Expected?

Yes

Costs and harms

Not assessed

Measurement

Studies

Not assessed

Study design

Not assessed

Measurement

Not assessed

Setting and sample

Not assessed

Measures

Not assessed

Comparison

Assumed alternative: no electrocardiograph on board the ship

Results

Assumed comparison. Result: Within seconds, the application confirmed the diagnostic hypothesis.

Additional value from AI

Not assessed

Limitations

Not assessed

Denominators

Not assessed

Materials for replication

Not assessed

Money

Kind of value

Not assessed

Amount

Not assessed

Currency and prices

Not assessed

Period and unit

Not assessed

Realization

Not assessed

Recipients and payers

Not assessed

Gross or net

Not assessed

Included costs

Not assessed

Comparison

Not assessed

Method

Not assessed

Return and payback

Not assessed

People and places

Participants

Developer: Not stated (the report does not name the device's maker). Operator: Centro Internazionale Radio Medico (CIRM), the Italian Telemedical Maritime Assistance Service, with the ship's captain.

Jurisdictions

Benefit: Indian Ocean (merchant ship), with the CIRM center in Rome, Italy. Operator: Italy.

Ownership and control

Not assessed

Dependencies

Not assessed

Cross-border connections

Not assessed

Geopolitical implications

Not assessed

Follow-up

Conditions for replication

The app's AF classification and the remote doctor's reading of the trace agree, as they did here and as the hospital ECG later confirmed. A port is within reach for diversion and the patient remains stable on the drugs available on board.

Replication attempts

Not assessed

Later findings

Not assessed

Availability

Not assessed

Institutional decision

Not assessed

Grounds

Not assessed

Action and result

Not assessed

Success criterion

Not assessed

Evidence

Source numbers

AIBD-0287-source-0001–0003

Citations

Numbered references below.

Language

Not assessed

Source relationships

Operator

Original evidence

Not assessed

Access and versions

Not assessed

Supported findings

Not assessed

Evidence strength

Not assessed

Missing evidence

Not assessed

Grades

Assessed benefits

People. Organizations.

Depth

People: 2. Organizations: 1.

Reasons

People: The seafarer received a diagnosis, rate control and aspirin at sea, diversion to port and hospital confirmation. He was repatriated without complications. Material: the authors say the service “has the potential to save lives”, but no life-threatening complication is documented. Organizations: CIRM's duty doctor could make a rhythm diagnosis and a diversion decision on an ECG trace rather than on symptoms alone. The report gives no measure beyond the single decision.

Observed or intended

Not assessed

Rubric

Not assessed

Assessor and date

Not assessed

Alternative assessments

Not assessed

Fill

The deployer's account

Entry details

Kind

Not assessed

Field

Healthcare (maritime telemedicine; cardiology). Consumer wearables.

Purpose

Smartwatch ECG apps are built to record a single-lead ECG and classify it for atrial fibrillation. This use, relayed to a telemedicine doctor, was that purpose in an unusual setting.

Dates

Date basis unassessed: 2023 (precision unassessed). Updated: 21 October 2026.

Stage

Not assessed

Version

SHA-256: 900ddc2cd62a…

References

Other identifiers

Not assessed

Category mappings

Not assessed

Brief

Not assessed

Revisions

5 revisions. Latest: 21 October 2026.

Sources

  1. Case report Deployer

    Ruocco C, Amenta F, Angeloni U, Frisicale EM, Vaia F, Sagaro GG (2025). A smartwatch electrocardiogram for atrial fibrillation detection: a case report. International Maritime Health 76(2):93-96. doi:10.5603/imh.99319 (open access, CC BY-NC-ND).

  2. Case report Deployer

    Ruocco C et al. (2025), Int Marit Health 76(2):93-96, diversion.